Sol-Gel Technologies (SLGL) Profit After Tax Growth (3y) (2020 - 2026)
Sol-Gel Technologies (SLGL) Profit After Tax Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 9.53% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -27.65% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 70.25% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Sol-Gel Technologies | 226.64 Mn | 216.50 Mn | - | 44.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.97% |
| Dec 31, 2025 | 41.50% |
| Sep 30, 2025 | 33,988.96% |
| Jun 30, 2025 | 105,001.94% |
| Mar 31, 2025 | 137.13% |
| Dec 31, 2024 | -45.68% |
| Sep 30, 2024 | -31.71% |
| Jun 30, 2024 | 17,706.27% |
| Mar 31, 2024 | 133.79% |
| Dec 31, 2023 | 54.72% |
| Sep 30, 2023 | -38.60% |
| Jun 30, 2023 | 26,704.28% |
| Mar 31, 2023 | 9.22% |
| Dec 31, 2022 | 15.36% |
| Sep 30, 2022 | -33.99% |
| Jun 30, 2022 | -66.24% |
| Mar 31, 2022 | -7.17% |
| Dec 31, 2021 | 27,887.85% |
| Sep 30, 2021 | 14,659.12% |
| Jun 30, 2021 | -0.93% |